Literature DB >> 22895815

Profiling of miRNAs in pediatric asthma: upregulation of miRNA-221 and miRNA-485-3p.

Feng Liu1, Hou-Bing Qin, Bing Xu, Hui Zhou, De-Yu Zhao.   

Abstract

The aim of this study was to investigate the expression profiles of microRNAs (miRNAs) in pediatric asthma and to determine candidate miRNAs responsible for the pathogenesis of this disease. Microarrays were used to detect the differences in the miRNA expression levels between asthmatic children and controls. Airway inflammation was evaluated by cell counting and tissue biopsy in an ovalbumin (OVA)-induced murine asthma model. Real-time polymerase chain reaction (PCR) was used to verify the differentially expressed miRNAs. The targets of the identified miRNAs were analyzed by bioinformatic analysis. The sprouty-related protein with an EVH1 domain-2 (Spred-2) protein content was assessed by western blotting. Differences were observed in the expression of miRNAs between the asthmatic children and controls. Upregulation of miRNA-221 and miRNA-485-3p in pediatric asthmatics and murine asthma models were verified by real-time PCR. Spred-2, a predicted target of miRNA-221 and miRNA-485-3p, was downregulated in murine asthma models. Upregulation of miRNA-221 and miRNA-485-3p may regulate the pathogenesis of asthma.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22895815     DOI: 10.3892/mmr.2012.1030

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  38 in total

Review 1.  The role of microRNAs in chronic respiratory disease: recent insights.

Authors:  Lindsay R Stolzenburg; Ann Harris
Journal:  Biol Chem       Date:  2018-02-23       Impact factor: 3.915

Review 2.  MicroRNAs in Allergic Disease.

Authors:  Eishika Dissanayake; Yuzaburo Inoue
Journal:  Curr Allergy Asthma Rep       Date:  2016-09       Impact factor: 4.806

Review 3.  MicroRNAs as therapeutics for future drug delivery systems in treatment of lung diseases.

Authors:  Kamal Dua; Nicole G Hansbro; Paul S Foster; Philip M Hansbro
Journal:  Drug Deliv Transl Res       Date:  2017-02       Impact factor: 4.617

4.  Subtypes of asthma defined by epithelial cell expression of messenger RNA and microRNA.

Authors:  Prescott G Woodruff
Journal:  Ann Am Thorac Soc       Date:  2013-12

Review 5.  Epigenetic targets for novel therapies of lung diseases.

Authors:  Brian S Comer; Mariam Ba; Cherie A Singer; William T Gerthoffer
Journal:  Pharmacol Ther       Date:  2014-11-15       Impact factor: 12.310

6.  Downregulation of miRNA-451a Promotes the Differentiation of CD4+ T Cells towards Th2 Cells by Upregulating ETS1 in Childhood Asthma.

Authors:  Tianyue Wang; Qianlan Zhou; Yunxiao Shang
Journal:  J Innate Immun       Date:  2020-12-03       Impact factor: 7.349

Review 7.  Diagnostic Potential of Extracellular MicroRNA in Respiratory Diseases.

Authors:  Dhamotharan Pattarayan; Rajesh K Thimmulappa; Vilwanathan Ravikumar; Subbiah Rajasekaran
Journal:  Clin Rev Allergy Immunol       Date:  2018-06       Impact factor: 8.667

Review 8.  The roles of microRNAs and protein components of the microRNA pathway in lung development and diseases.

Authors:  Leah Cushing; Zhihua Jiang; Pingping Kuang; Jining Lü
Journal:  Am J Respir Cell Mol Biol       Date:  2015-04       Impact factor: 6.914

Review 9.  Circulating microRNAs as biomarkers for inflammatory diseases.

Authors:  Shuangli Mi; Jian Zhang; Wei Zhang; R Stephanie Huang
Journal:  Microrna       Date:  2013

Review 10.  Diagnostic, functional, and therapeutic roles of microRNA in allergic diseases.

Authors:  Thomas X Lu; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2013-06-02       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.